Duopharma Biotech Bhd
KLSE:DPHARMA
Wall Street
Price Targets
DPHARMA Price Targets Summary
Duopharma Biotech Bhd
According to Wall Street analysts, the average 1-year price target for DPHARMA is 1.73 MYR with a low forecast of 1.67 MYR and a high forecast of 1.83 MYR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DPHARMA's stock price target?
Price Target
1.73
MYR
According to Wall Street analysts, the average 1-year price target for DPHARMA is 1.73 MYR with a low forecast of 1.67 MYR and a high forecast of 1.83 MYR.
What is Duopharma Biotech Bhd's Revenue forecast?
Projected CAGR
8%
For the last 13 years the compound annual growth rate for Duopharma Biotech Bhd's revenue is 15%. The projected CAGR for the next 3 years is 8%.
What is Duopharma Biotech Bhd's Operating Income forecast?
Projected CAGR
17%
For the last 13 years the compound annual growth rate for Duopharma Biotech Bhd's operating income is 9%. The projected CAGR for the next 3 years is 17%.
What is Duopharma Biotech Bhd's Net Income forecast?
Projected CAGR
21%
For the last 13 years the compound annual growth rate for Duopharma Biotech Bhd's net income is 7%. The projected CAGR for the next 3 years is 21%.
